Ginestin has shown effects on Akt, NF-κB, matrix metalloproteinases (MMPs), and BAX/Bcl-2 signaling pathways for breast cancer prevention in C57Bl/6 mice (Sarkar and Li, 2002). This evidence concerns the gene BCL2 and breast carcinoma.